rs2250616

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001963.6(EGF):​c.127+1946G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 151,938 control chromosomes in the GnomAD database, including 6,692 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6692 hom., cov: 32)

Consequence

EGF
NM_001963.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.519

Publications

6 publications found
Variant links:
Genes affected
EGF (HGNC:3229): (epidermal growth factor) This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
EGF Gene-Disease associations (from GenCC):
  • familial primary hypomagnesemia with normocalciuria and normocalcemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal hypomagnesemia 4
    Inheritance: AD, AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001963.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.327 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001963.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGF
NM_001963.6
MANE Select
c.127+1946G>A
intron
N/ANP_001954.2P01133-1
EGF
NM_001178130.3
c.127+1946G>A
intron
N/ANP_001171601.1P01133-3
EGF
NM_001178131.3
c.127+1946G>A
intron
N/ANP_001171602.1P01133-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGF
ENST00000265171.10
TSL:1 MANE Select
c.127+1946G>A
intron
N/AENSP00000265171.5P01133-1
EGF
ENST00000503392.1
TSL:1
c.127+1946G>A
intron
N/AENSP00000421384.1P01133-3
EGF
ENST00000868530.1
c.127+1946G>A
intron
N/AENSP00000538589.1

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43882
AN:
151820
Hom.:
6692
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.251
Gnomad AMI
AF:
0.324
Gnomad AMR
AF:
0.261
Gnomad ASJ
AF:
0.381
Gnomad EAS
AF:
0.0843
Gnomad SAS
AF:
0.222
Gnomad FIN
AF:
0.300
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.331
Gnomad OTH
AF:
0.311
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.289
AC:
43896
AN:
151938
Hom.:
6692
Cov.:
32
AF XY:
0.283
AC XY:
20999
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.251
AC:
10405
AN:
41420
American (AMR)
AF:
0.261
AC:
3981
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.381
AC:
1323
AN:
3468
East Asian (EAS)
AF:
0.0849
AC:
439
AN:
5172
South Asian (SAS)
AF:
0.222
AC:
1065
AN:
4804
European-Finnish (FIN)
AF:
0.300
AC:
3165
AN:
10546
Middle Eastern (MID)
AF:
0.398
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
0.330
AC:
22457
AN:
67952
Other (OTH)
AF:
0.308
AC:
649
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1568
3136
4703
6271
7839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.311
Hom.:
1300
Bravo
AF:
0.287
Asia WGS
AF:
0.159
AC:
557
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.0
DANN
Benign
0.75
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2250616;
hg19: chr4-110836564;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.